Pharmacy
Bristol-Myers Squibb Announces Split-Off of Mead Johnson
The FINANCIAL -- Bristol-Myers Squibb Company (NYSE: BMY) on November 16 announced it will split off its holdings in Mead Johnson Nutrition...
Pandemrix data on co-administration with annual seasonal influenza vaccine (Fluarix)
The FINANCIAL -- GlaxoSmithKline (GSK) on November 9 announced the results from the clinical trial assessing Pandemrix, GSK’s adjuvanted H1N1 pandemic influenza...
Sanofi-aventis announces Changes to Executive Committee
The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on November 2 a number of changes to its Executive Committee....
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement
The FINANCIAL -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced on November 2 that they have...
Arena Pharma Reports Significant Phase 3 Data Showing Improved Markers Of Cardiovascular Risk
The FINANCIAL -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported that data from the pivotal BLOOM (Behavioral modification and Lorcaserin for...
FDA Determines VYVANSE was Properly Granted Five-Year Market Exclusivity
The FINANCIAL -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that the Food and Drug...
Biogen Idec Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Tria
The FINANCIAL -- Biogen Idec (NASDAQ: BIIB) and Biovitrum AB (STO: BVT) on October 19 announced that they plan to advance the companies’...
Takeda: Approval of an Additional Indication of BASEN
The FINANCIAL -- Takeda Pharmaceutical Company Limited (“Takeda”) announced that it has received approval from the Japanese Ministry of Health,...
Pfizer JAK-3 arthritis drug effective in studies
The FINANCIAL -- Pfizer Inc announced on October 18 that 24-week data from two clinical studies of the oral JAK inhibitor, CP-690,550,...
Novartis receives Complete Response letter from FDA for QAB149
The FINANCIAL -- Novartis has received a Complete Response letter from the US Food and Drug Administration (FDA) as part...
Merial invests US $ 70 million in Nanchang, China
The FINANCIAL -- Merial, the Animal Health division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced on October 12 that...
License to Market Kremezin(R) (drug for chronic renal failure) in Japan
The FINANCIAL -- KUREHA CORPORATION (Head office: Chuo-ku, Tokyo; President & CEO: Takao Iwasaki; hereinafter, "KUREHA") and Mitsubishi Tanabe Pharma...
Sandoz launches somatropin increasing access to key medicines in second largest global market
The FINANCIAL -- Sandoz on October 5 announced the launch of its recombinant human growth hormone somatropin in Japan, the first-ever biosimilar...
Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA
The FINANCIAL -- Merck & Co., Inc. announced on September 28 that the Company has entered into an exclusive agreement with...
Johnson & Johnson Buys Crucell shares for 302 million euros
The FINANCIAL -- U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in Dutch...
ADVERTISEMENT
Popular Last 24h
-
Zebra dies after ‘incident’with rhino at zoo
-
Government Contractor Agrees to Pay $1M to Resolve False Claims Act Allegations for Submitting Fraudulent Bids on Prime Vendor Contracts
-
Giant Pandas Will Make Their Public Debut Jan. 24 at Smithsonian’s National Zoo and Conservation Biology Institute
-
Gerald Durrell’s Centenary: a year of celebrations starts today
-
Minnesota Man Sentenced To 15 Months For Trafficking In Stolen Human Remains
-
How the Aging Brain Affects Thinking
-
ICE Acquires the American Financial Exchange (AFX)
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
